These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


78 related items for PubMed ID: 2832964

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Monitoring of plasma concentration of low molecular weight heparin--comparative evaluation with chromogenic and clotting assays].
    Katagiri H, Itoh S, Uchida T, Kawai Y, Watanabe K.
    Rinsho Byori; 1999 Nov; 47(11):1046-51. PubMed ID: 10590682
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK, Berry LR, Monagle PT, Andrew M.
    Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
    Atkinson HM, Mewhort-Buist TA, Berry LR, Chan AK.
    Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
    [Abstract] [Full Text] [Related]

  • 28. Unfractionated heparin infusion for thromboprophylaxis in highest risk gastric bypass surgery.
    F Shepherd M, Rosborough TK, Schwartz ML.
    Obes Surg; 2004 May; 14(5):601-5. PubMed ID: 15186625
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Continuous hemofiltration with a low molecular weight heparin, enoxaparine: report on two cases.
    Lorenzini JL, Freysz M, Honnart D, Zeller V, Dutrillaux F.
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):89-91. PubMed ID: 1649141
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R.
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin.
    Young E, Wells P, Holloway S, Weitz J, Hirsh J.
    Thromb Haemost; 1994 Mar; 71(3):300-4. PubMed ID: 8029793
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.